GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OTCPK:ATVBY) » Definitions » Cyclically Adjusted PS Ratio

Active Biotech AB (Active Biotech AB) Cyclically Adjusted PS Ratio : (As of Jun. 13, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Active Biotech AB Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Active Biotech AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Active Biotech AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Cyclically Adjusted PS Ratio Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 3.09 - - -

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Active Biotech AB's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Active Biotech AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Cyclically Adjusted PS Ratio falls into.



Active Biotech AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Active Biotech AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Active Biotech AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/132.2054*132.2054
=0.000

Current CPI (Mar. 2024) = 132.2054.

Active Biotech AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.004 100.432 0.005
201409 0.003 100.161 0.004
201412 0.003 100.225 0.004
201503 0.003 99.950 0.004
201506 0.003 99.995 0.004
201509 0.005 100.228 0.007
201512 0.005 100.276 0.007
201603 0.004 100.751 0.005
201606 0.004 101.019 0.005
201609 0.004 101.138 0.005
201612 0.006 102.022 0.008
201703 0.004 102.022 0.005
201706 0.005 102.752 0.006
201709 0.005 103.279 0.006
201712 0.005 103.793 0.006
201803 0.001 103.962 0.001
201806 0.001 104.875 0.001
201809 0.004 105.679 0.005
201812 0.004 105.912 0.005
201903 0.001 105.886 0.001
201906 0.001 106.742 0.001
201909 0.001 107.214 0.001
201912 0.001 107.766 0.001
202003 0.000 106.563 0.000
202006 0.000 107.498 0.000
202009 0.000 107.635 0.000
202012 0.006 108.296 0.007
202103 0.000 108.360 0.000
202106 0.000 108.928 0.000
202109 0.000 110.338 0.000
202112 0.000 112.486 0.000
202203 0.000 114.825 0.000
202206 0.000 118.384 0.000
202209 0.000 122.296 0.000
202212 0.000 126.365 0.000
202303 0.000 127.042 0.000
202306 0.000 129.407 0.000
202309 0.000 130.224 0.000
202312 0.000 131.912 0.000
202403 0.000 132.205 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Active Biotech AB  (OTCPK:ATVBY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Active Biotech AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Active Biotech AB (Active Biotech AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (Active Biotech AB) Headlines

No Headlines